Robert S. Langer

"Dr. Langer’s many awards include the US National Medal of Science, the US National Medal of Technology and Innovation, the Charles Stark Draper Prize (considered the engineering Nobel Prize), Albany Medical Center Prize (largest US medical prize), the Priestley Medal (2012), the Queen Elizabeth Prize (2015), the Wolf Prize for Chemistry, the 2014 Kyoto Prize, the 2019 Dreyfus Prize, and the Lemelson-MIT prize, for being “one of history’s most prolific inventors in medicine.” Langer is one of the very few individuals ever elected to the National Academy of Medicine, the National Academy of Engineering and the National Academy of Sciences. In 2020, he was named a Fellow of the American Association for Cancer Research’s AACR Academy.

"Robert Langer is a co-founder of many entities, including Momenta and Living Proof. He also serves on the Board of Directors of Moderna and Puretech, and serves as an advisor to a number of other companies."

"Dr. Langer serves as an advisor to: 7th Sense, Abpro, Allevi, Alnylam, Artificial Cells, Arsenal Medical, Celero, Cellomics, Cellular Biomedical, Combined Therapeutics, Dewpoint, Eagle, Evox, Frequency Therapeutics, , Glycobia, Glympse, Greenlight, HKF Technologies, Humacyte, In Vivo Therapeutics, Landsdowne Labs, Like Minds, Luminopia, Luye, Lyndra, Lyra, Moderna, Momenta, Monsanto, Mylan, Nanobiosym, Nanobiotix, Noveome, Particles for Humanity, Polaris, Portal, Puretech, Rubius, Selecta Biosciences, Shiseido, Sigilon, Sio2, SQZ, Stembiosys, Suono Bio, T2 Biosystems, Tara, Taris Biomedical, Tarveda, Tiba, Tissium, Unilever, VasoRX, Verseau Therapeutics, Vivtex, Zenomics." [1]